(Q38846856)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

title

Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

main subject

hepatocellular carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Alexis Laurent

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Jean-Michel Pawlotsky

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

author name string

Julien Calderaro

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Giuliana Amaddeo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Marion Mercey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Cécile Charpy

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Charlotte Costentin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Alain Luciani

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Elie-Serge Zafrani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Daniel Azoulay

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

Fouad Lafdil

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

language of work or name

English

0 references

publication date

9 August 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

volume

64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

page(s)

2038-2046

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

17 March 2020

cites work

1 reference

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

21 January 2018

1 reference

21 January 2018

Hepatocellular carcinoma

1 reference

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

21 January 2018

1 reference

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

Immune checkpoint blockade: a common denominator approach to cancer therapy

21 January 2018

1 reference

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

21 January 2018

1 reference

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer

21 January 2018

1 reference

The PD-1/PD-Ls pathway and autoimmune diseases

21 January 2018

1 reference

Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion

21 January 2018

1 reference

Blockade of B7-H1 improves myeloid dendritic cell–mediated antitumor immunity

21 January 2018

1 reference

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

21 January 2018

1 reference

PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy

21 January 2018

1 reference

Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells.

21 January 2018

1 reference

A fibrous stromal component in hepatocellular carcinoma reveals a cholangiocarcinoma-like gene expression trait and epithelial-mesenchymal transition.

21 January 2018

1 reference

Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment

21 January 2018

1 reference

PD-L1 expression in small cell neuroendocrine carcinomas

21 January 2018

1 reference

PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas.

21 January 2018

1 reference

Characterization of inflammatory (lymphoepithelioma-like) hepatocellular carcinoma: a study of 8 cases.

21 January 2018

1 reference

Lymphoepithelioma-like hepatocellular carcinoma: an uncommon variant of hepatocellular carcinoma with favorable outcome

21 January 2018

1 reference

Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas

21 January 2018

1 reference

Tumor-infiltrating programmed death receptor-1+ dendritic cells mediate immune suppression in ovarian cancer

21 January 2018

1 reference

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.

21 January 2018

1 reference

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

21 January 2018

1 reference

Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells.

21 January 2018

1 reference

Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity

21 January 2018

1 reference

The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Human hepatocellular carcinomas with "Stemness"-related marker expression: keratin 19 expression and a poor prognosis

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.28710

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27359084%20AND%20SRC:MED&resulttype=core&format=json

17 March 2020

1 reference